Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study

References

• Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, . Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725–30.
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853–60.
   PubMed Web of Science ®Google Scholar
• Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, . Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med 2007;146:87–95.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, . Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy. AIDS 2004;18:2333–7.
   PubMedGoogle Scholar
• Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 2006;163:412–20.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Arenas MA, Jarrin I, Del Amo J, Iribarren JA, Moreno S, Viciana P, . Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses 2006;22:715–23.
   PubMed Web of Science ®Google Scholar
• Larsen M, Omland L, Gerstoft J, Larsen C, Jensen J, Obel N, . Impact of injecting drug use on mortality in Danish HIV infected patients: a nationwide population based cohort study. Addiction 2009;105:529–35.
   Google Scholar
• Prins M, Sabin CA, Lee CA, Devereux H, Coutinho RA. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men. AIDS 2000;14:1829–37.
   PubMed Web of Science ®Google Scholar
• Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, . Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol 2005;161:999–1012.
   PubMed Web of Science ®Google Scholar
• Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis 2007;45(Suppl 4):S318–23.
   PubMedGoogle Scholar
• Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, . Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815–26.
   PubMed Web of Science ®Google Scholar
• Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, . Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547–9.
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995;333:751–6.
   PubMed Web of Science ®Google Scholar
• Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003;169:656–61.
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Population in Denmark, 1st January 2007. Available at: www.statistikbanken.dk.
   Google Scholar
• Lohse N, Hansen AB, Jensen-Fangel S, Kronborg G, Kvinesdal B, Pedersen C, . Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005;37:338–43.
   PubMed Web of Science ®Google Scholar
• Sundhedsstyrelsen. Narkotikasituationen i Danmark 2008. Denmark: National Board of Health. Available at: www.sst.dk/publ/Publ2008/CFF/Narkotika/NarkoRapport_08_web.pdf (accessed 1st January 2007).
   Google Scholar
• Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV Cohort Study. Int J Epidemiol 2009;38:1202–6.
   PubMed Web of Science ®Google Scholar
• Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Moller A, . The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002; 35:1541–8.
   PubMed Web of Science ®Google Scholar
• Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, . Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med 2009;10:407–16.
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, . Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009;338:b1649.
   PubMed Web of Science ®Google Scholar
• Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, . Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001;15:1707–15.
   PubMed Web of Science ®Google Scholar
• Wood E, Hogg RS, Yip B, Dong WW, Wynhoven B, Mo T, . Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS 2005;19:1189–95.
   PubMedGoogle Scholar
• Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA, III, . Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004;350:1850–61.
   PubMed Web of Science ®Google Scholar
• Jorgensen LB, Christensen MB, Gerstoft J, Mathiesen LR, Obel N, Pedersen C, . Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. Scand J Infect Dis 2003;35:800–7.
   PubMedGoogle Scholar
• Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, . Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis 2006;42:1481–7.
   PubMed Web of Science ®Google Scholar